ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.49
-0.08 (-5.10%)
As of Mar 31, 10:16 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +145.0% upside
Low Target $2.40
Average Target $3.65
High Target $4.80
Current Price $1.49
Current
$1.49
Target
$3.65
$2.40 $3.65 avg $4.80
Scenario Analysis
Bear Case
$2.40
61.1%
Low target
Base Case
$3.65
+145.0%
Avg target
Bull Case
$4.80
+222.1%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$74.30
-98.0% from high
52-Week Low
$2.20
+-32.3% from low
Target vs 52W High
$3.65
-95.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
 Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -28.5%